Cargando…
Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment
[Image: see text] Osteoporosis is the most common disease involving bone degeneration. Current clinical treatments are not able to offer a satisfying curative effect, so the development of effective treatments is desired. Gene silencing through siRNA delivery has gained great attention as a potentia...
Autores principales: | Mora-Raimundo, Patricia, Lozano, Daniel, Manzano, Miguel, Vallet-Regí, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588271/ https://www.ncbi.nlm.nih.gov/pubmed/31071265 http://dx.doi.org/10.1021/acsnano.9b00241 |
Ejemplares similares
-
Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles
por: Mora‐Raimundo, Patricia, et al.
Publicado: (2021) -
Pleiotrophin-Loaded Mesoporous Silica Nanoparticles as a Possible Treatment for Osteoporosis
por: Lozano, Daniel, et al.
Publicado: (2023) -
Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis
por: Gisbert-Garzarán, Miguel, et al.
Publicado: (2020) -
An Overview of the Use of Nanoparticles in Vaccine Development
por: Lozano, Daniel, et al.
Publicado: (2023) -
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
por: Vallet-Regí, María, et al.
Publicado: (2022)